These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Rozemuller JM; Abbink JJ; Kamp AM; Stam FC; Hack CE; Eikelenboom P Acta Neuropathol; 1991; 82(3):200-7. PubMed ID: 1927277 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
32. Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. Pasternack JM; Abraham CR; Van Dyke BJ; Potter H; Younkin SG Am J Pathol; 1989 Nov; 135(5):827-34. PubMed ID: 2817081 [TBL] [Abstract][Full Text] [Related]
33. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease. Murphy GM; Sullivan EV; Gallagher-Thompson D; Thompson LW; van Duijn CM; Forno LS; Ellis WG; Jagust WJ; Yesavage J; Tinklenberg JR Neurology; 1997 May; 48(5):1313-6. PubMed ID: 9153464 [TBL] [Abstract][Full Text] [Related]
34. CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease. Mulder SD; Heijst JA; Mulder C; Martens F; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R Ann Clin Biochem; 2009 Nov; 46(Pt 6):477-83. PubMed ID: 19729499 [TBL] [Abstract][Full Text] [Related]
35. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Abraham CR; Shirahama T; Potter H Neurobiol Aging; 1990; 11(2):123-9. PubMed ID: 2190106 [TBL] [Abstract][Full Text] [Related]
36. Developmental expression of alpha 1-antichymotrypsin in brain may be related to astrogliosis. Koo EH; Abraham CR; Potter H; Cork LC; Price DL Neurobiol Aging; 1991; 12(5):495-501. PubMed ID: 1837594 [TBL] [Abstract][Full Text] [Related]
37. Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons. Wen GY; Wisniewski HM; Blondal H; Benedikz E; Frey H; Pirttila T; Rudelli R; Kim KS Acta Neuropathol; 1994; 88(3):201-6. PubMed ID: 7810290 [TBL] [Abstract][Full Text] [Related]
38. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans. Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998 [TBL] [Abstract][Full Text] [Related]
39. Vitamin E and Alzheimer's disease in subjects with Down's syndrome. Jackson CV; Holland AJ; Williams CA; Dickerson JW J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():479-84. PubMed ID: 2976843 [TBL] [Abstract][Full Text] [Related]
40. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. Kamboh MI; Minster RL; Kenney M; Ozturk A; Desai PP; Kammerer CM; DeKosky ST Neurobiol Aging; 2006 Oct; 27(10):1435-9. PubMed ID: 16137793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]